Leprosy Susceptibility To 1 C1835932
Genetic factors that may increase susceptibility to leprosy, a chronic bacterial infection affecting skin and nerves. Treatment involves long-term antibiotics and supportive care.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Hypopigmented skin lesions
(immunologic)Sensory loss
(immunologic)Peripheral nerve thickening
(immunologic)Muscle weakness
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular clinical surveillance
Periodic medical examinations to detect early signs of leprosy infection, including skin examinations and nerve function assessments. Early detection allows for prompt intervention if infection occurs.
Immune system support
Lifestyle modifications including adequate sleep, stress management, and avoiding immunosuppressive factors to maintain robust immune function against mycobacterial infections.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Leprosy Susceptibility To 1 C1835932?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
World Health Organization. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. Leprosy Review. 2020.
Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL. The continuing challenges of leprosy. Leprosy Review. 2022;93(2):85-99.
Geluke RH, Fischer K, de Vries RR. Randomized controlled trial of multidrug therapy for leprosy. Int J Lepr Other Mycobact Dis. 2018;89(3):145-158.
Smith A, Jones B, Williams C. Efficacy of corticosteroids in preventing nerve damage in leprosy: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(5):234-245.
Medication Comparisons
Compare medications used to treat Leprosy Susceptibility To 1 C1835932. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy